Induction of epithelial-to-mesenchymal transition in proximal tubular epithelial cells on microfluidic devices

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1390-1401

  Zhou, Mengying ^a   Ma, Huipeng ^a,b   Lin, Hongli ^a   Qin, Jianhua ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Biomimetic of proximal tubule; C3a; Epithelial to mesenchymal transition; Microfluidic; Migration

Indexed keywords

BIOMIMETICS; CELL CULTURE; FLUIDIC DEVICES; PROTEINS;

BASEMENT MEMBRANE; EPITHELIAL TO MESENCHYMAL TRANSITIONS; MICRO-FLUIDIC DEVICES; MIGRATION; MORPHOLOGICAL CHANGES; PATHOLOGICAL PROCESS; PROXIMAL TUBULES; RENAL INTERSTITIAL FIBROSIS;

MICROFLUIDICS;

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; COMPLEMENT COMPONENT C3A; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

APOPTOSIS; ARTICLE; BIOMIMETICS; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE CELL; MICROFLUIDICS; PHENOTYPE; PRIORITY JOURNAL;

BIOMIMETIC OF PROXIMAL TUBULE; C3A; EPITHELIAL-TO-MESENCHYMAL TRANSITION; MICROFLUIDIC; MIGRATION;

APOPTOSIS; CELL LINE, TRANSFORMED; CELL MOVEMENT; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KIDNEY TUBULES, PROXIMAL; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84890159896     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.070     Document Type: Article

References (36)

1. Tang R., Yang C., Tao J.L., You Y.K., An N., Li S.M., et al. Epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells induced by urinary proteins requires the activation of PKC-alpha and betaI isozymes. Cell Biol Int 2011, 35:953-959.
2. Bakris G.L. Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol 2008, 3(Suppl.1):S3-S10.
3. Neilson E.G. Mechanisms of disease: fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2006, 2:101-108.
4. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. JClin Invest 2009, 119:1420-1428.
5. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010, 176:85-97.
6. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010, 177:632-643.
7. Grgic I., Duffield J.S., Humphreys B.D. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2012, 27:183-193.
8. Whitesides G.M. The origins and the future of microfluidics. Nature 2006, 442:368-373.
9. El-Ali J., Sorger P.K., Jensen K.F. Cells on chips. Nature 2006, 442:403-411.
10. Khetani S.R., Bhatia S.N. Microscale culture of human liver cells for drug development. Nat Biotechnol 2008, 26:120-126.
11. Liu T., Li C., Li H., Zeng S., Qin J., Lin B. Amicrofluidic device for characterizing the invasion of cancer cells in 3-D matrix. Electrophoresis 2009, 30:4285-4291.
12. Liu T., Lin B., Qin J. Carcinoma-associated fibroblasts promoted tumor spheroid invasion on a microfluidic 3D co-culture device. Lab Chip 2010, 10:1671-1677.
13. Huh D., Matthews B.D., Mammoto A., Montoya-Zavala M., Hsin H.Y., Ingber D.E. Reconstituting organ-level lung functions on a chip. Science 2010, 328:1662-1668.
14. Peyrin J.M., Deleglise B., Saias L., Vignes M., Gougis P., Magnifico S., et al. Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. Lab Chip 2011, 11:3663-3673.
15. Doi S., Zou Y., Togao O., Pastor J.V., John G.B., Wang L., et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. JBiol Chem 2011, 286:8655-8665.
16. Lin H., Wang D., Wu T., Dong C., Shen N., Sun Y., et al. Blocking core fucosylation of TGF-beta1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol 2011, 300:F1017-F1025.
17. Ibrini J., Fadel S., Chana R.S., Brunskill N., Wagner B., Johnson T.S., et al. Albumin-induced epithelial mesenchymal transformation. Nephron Exp Nephrol 2012, 120:e91-102.
18. Abbate M., Zoja C., Corna D., Rottoli D., Zanchi C., Azzollini N., et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. JAm Soc Nephrol 2008, 19:1158-1167.
19. Duffy D.C., McDonald J.C., Schueller O.J., Whitesides G.M. Rapid prototyping ofmicrofluidic systems in poly(dimethylsiloxane). Anal Chem 1998, 70:4974-4984.
20. Bijuklic K., Jennings P., Kountchev J., Hasslacher J., Aydin S., Sturn D. t al. Migration of leukocytes across an endothelium-epithelium bilayer as a modelof renal interstitial inflammation. Am J Physiol Cell Physiol 2007, 293:C486-C492.
21. Filippi-Chiela E.C., Oliveira M.M., Jurkovski B., Callegari-Jacques S.M., da Silva V.D., Lenz G. Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One 2012, 7:e42522.
22. Ye N., Qin J., Shi W., Liu X., Lin B. Cell-based high content screening using an integrated microfluidic device. Lab Chip 2007, 7:1696-1704.
23. Li K., Patel H., Farrar C.A., Hargreaves R.E., Sacks S.H., Zhou W. Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. JAm Soc Nephrol 2004, 15:2414-2422.
24. Moses H.L., Branum E.L., Proper J.A., Robinson R.A. Transforming growth factor production by chemically transformed cells. Cancer Res 1981, 41:2842-2848.
25. Lesher A.M., Song W.C. Review: complement and its regulatory proteins in kidney diseases. Nephrology (Carlton) 2010, 15:663-675.
26. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. JClin Invest 2009, 119:1429-1437.
27. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. JAm Soc Nephrol 2004, 15:1-12.
28. Kriz W., Kaissling B., Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. JClin Invest 2011, 121:468-474.
29. Oehring H., Widder J., Appenroth D., Jirikowski G.F., Fleck C. Ultrastructural and ultraimmunohistochemical changes upon partial nephrectomy and uranyl intoxication in the rat kidney. Exp Toxicol Pathol 2013, 65:441-449.
30. Samejima K., Nakatani K., Suzuki D., Asai O., Sakan H., Yoshimoto S., et al. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Nephron Clin Pract 2012, 120:c1-c7.
31. Jinde K., Nikolic-Paterson D.J., Huang X.R., Sakai H., Kurokawa K., Atkins R.C., et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001, 38:761-769.
32. Tang Z., Lu B., Hatch E., Sacks S.H., Sheerin N.S. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. JAm Soc Nephrol 2009, 20:593-603.
33. Liu F., Gou R., Huang J., Fu P., Chen F., Fan W.X., et al. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation invitro. Chin Med J (Engl) 2011, 124:4039-4045.
34. Braun M.C., Reins R.Y., Li T.B., Hollmann T.J., Dutta R., Rick W.A., et al. Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. JImmunol 2004, 173:4190-4196.
35. Thurman J.M., Lenderink A.M., Royer P.A., Coleman K.E., Zhou J., Lambris J.D., et al. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. JImmunol 2007, 178:1819-1828.
36. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. JClin Invest 2002, 110:341-350.